Abstract
To elucidate the Tau gain-of-toxicity functional mechanism and to search for potential treatments, we overexpressed human Tau variants (hTau) in the dorsal mesothorax (notum) of Drosophila. Overexpression of Tau variants caused loss of notal bristles, and the phenotype was used for evaluating toxicity of ectopic Tau. The bristle loss phenotype was found to be highly associated with the toxicity of hyperphosphoryled Tau in flies. We have shown that the bristle loss phenotype can be rescued either by reducing Glycogen synthase kinase 3beta (GSK3beta)/Shaggy (Sgg) activity or overexpressing Bbeta2 regulatory subunits of PP2A. Elevated expression of the Drosophila Bbeta2 homolog, Twins (Tws), also alleviated neuritic dystrophy of the dorsal arborization (da) neuron caused by Tau aggregation. Additionally, lowering endogenous Tau dosage was beneficial as it ameliorated the bristle loss phenotype. Finally, the bristle loss phenotype was used to evaluate the efficacy of potential therapeutic compounds. The GSK3beta inhibitor, alsterpaullone, was found to suppress toxicity of Tau in a concentration-dependent manner. The notum of Drosophila, thus, provides a new tool and insights into Tau-induced toxicity. It could also potentially assi...Continue Reading
References
Jan 1, 1994·Annual Review of Genetics·Y N Jan, L Y Jan
Dec 1, 1995·Neuroscience·T ArendtU Gärtner
Dec 1, 1996·Neuron·E SontagM C Mumby
Dec 14, 1999·The American Journal of Pathology·K SpittaelsF Van Leuven
Mar 22, 2001·Experimental Neurology·V Vogelsberg-RagagliaV M Lee
Jun 16, 2001·Science·C W WittmannM B Feany
Jun 14, 2002·Neuron·George R JacksonDaniel H Geschwind
Sep 27, 2002·Genesis : the Journal of Genetics and Development·Chiou-Yang Tang, Y Henry Sun
Apr 30, 2003·The Journal of Biological Chemistry·Ruben K DagdaStefan Strack
Jul 23, 2003·Development·Hélène DoerflingerDaniel St Johnston
Dec 12, 2003·Genetics·Joshua M Shulman, Mel B Feany
Feb 20, 2004·Development·Ruchi BajpaiL S Shashidhara
May 28, 2005·The American Journal of Pathology·Hitoshi TanimukaiKhalid Iqbal
Jun 9, 2006·Biochemical and Biophysical Research Communications·Katy Wing-Kam ChauHo-Yin Edwin Chan
Jun 30, 2006·FEBS Letters·Muhammad Omar ChohanKhalid Iqbal
Dec 14, 2006·Development·Wesley B GrueberYuh-Nung Jan
Dec 19, 2006·The Journal of Clinical Investigation·Dora Dias-SantagataMel B Feany
Mar 6, 2007·Journal of Neuroscience Research·Michelle L SteinhilbMel B Feany
Oct 2, 2007·British Journal of Pharmacology·M-L SelenicaJ Lotharius
Oct 12, 2007·Molecular Biology of the Cell·Michelle L SteinhilbMel B Feany
May 17, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chiung-Mei ChenGuey-Jen Lee-Chen
Oct 22, 2008·Human Molecular Genetics·Shreyasi ChatterjeeGeorge R Jackson
Jan 24, 2009·Trends in Neurosciences·Tara L Spires-JonesBradley T Hyman
Citations
Feb 13, 2013·Molecular Psychiatry·J ChapuisUNKNOWN GERAD consortium
Apr 8, 2011·The Journal of Biological Chemistry·Yu-Chun WangMing-Tsan Su
Jun 28, 2011·Human Molecular Genetics·Yasmina Talmat-AmarMarie-Laure Parmentier
Aug 20, 2010·International Journal of Alzheimer's Disease·Thorsten KoechlingJesus Avila
Jun 16, 2012·International Journal of Alzheimer's Disease·Marc GistelinckPierre Dourlen
Jan 24, 2018·BioMed Research International·Xiaocong PangGuan-Hua Du
Oct 5, 2017·PloS One·Po-An Yeh, Ching-Jin Chang
Jan 22, 2019·Expert Opinion on Drug Discovery·Katerina PapanikolopoulouEfthimios Skoulakis
Jun 18, 2011·Molecular Neurobiology·Katerina Papanikolopoulou, Efthimios M C Skoulakis